Bioventus products, orthobiologics, biologics and devices for bone healing and osteoartritis pain relief are known as innovations for active healing.
Location: United States, North Carolina, Durham
Investors 2
| Date | Name | Website |
| - | Alta Partn... | altapartne... |
| - | EW Healthc... | ewhealthca... |
Mentions in press and media 15
| Date | Title | Description |
| 04.10.2021 | EW Healthcare Partners Announces the Promotion of Senior Executives | Oct 04 2021 NEW YORK, New York – EW Healthcare Partners (“EW”), a leading healthcare growth equity firm with a global investment practice, has announced the promotion of senior executives of their investment team. • Brooks Andrews has bee... |
| 30.03.2021 | Bioventus Acquires Bioness, Inc. | Mar 30 2021 DURHAM, North Carolina –– Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has acquired Bioness, Inc. (“Bioness”), a global leader in neuromodulation and rehabilita... |
| 10.02.2021 | Bioventus Announces Pricing of Initial Public Offering | Feb 10 2021 DURHAM, North Carolina(GLOBE NEWSWIRE)—Bioventus Inc. (“Bioventus” or the “Company”) today announced the pricing of its initial public offering of 8,000,000 shares of Class A common stock at a public offering price of $13.00 pe... |
| 19.07.2020 | Bioventus Makes $15 Million Equity Investment in CartiHeal | KFAR SABA, Israel & DURHAM, N.C.--(BUSINESS WIRE)--CartiHeal, developer of the proprietary Agili™-C implant for the treatment of joint surface lesions in traumatic and osteoarthritic joints, has secured an additional $15 million equity ... |
| 02.07.2020 | MiMedx Announces Concurrent $150 Million Private Equity and Debt Financings | Jul 02 2020 Equity Financing Led by EW Healthcare Partners and Debt Financing Provided by Hayfin Capital Management. EW Healthcare Partners Managing Director and Co-Founder Martin Sutter and Former Medtronic Chairman and CEO William Hawkin... |
| 17.01.2019 | Bioventus launches Osteomatrix+ bone graft | Bioventus announced today that it has started selling Osteomatrix+ – a moldable bone graft substitute intended for a variety of orthopedic and spine bone remodeling applications. Bioventus officials boast that Osteomatrix+ has improved mold... |
| 10.10.2018 | EW Healthcare Partners Announces the Appointment of Two Senior Executives | Oct 10 2018 NEW YORK, New York – EW Healthcare Partners (“EW”), a leading healthcare growth equity firm with a global investment practice, has announced the addition of two senior executives to their investment team: • Olivier Bohuon, for... |
| 01.02.2018 | CartiHeal Secures $2.5M in Funding | CartiHeal, a Kfar Saba, Israel-based developer of the proprietary Agili-C implant for the treatment of joint surface lesions in traumatic and osteoarthritic joints, secured $2.5M in funding. Bioventus made the investment, which complements ... |
| 18.10.2017 | EW Healthcare Partners Announces the Appointment of Three Senior Executives | Oct 18 2017 NEW YORK, New York—EW Healthcare Partners (“EW”), a leading healthcare growth equity firm with a global investment practice, has announced the addition of three senior executives to their investment team: • Lamberto Andreotti,... |
| 01.07.2016 | 5 takeaways from Bioventus IPO move | What’s it for? Bioventus only provided a $150 million estimate for how much it intends to raise through the proposed IPO. But according to the offering documents, the money would be used to pay down debt some of the company’s $60 million de... |
Show more